Some Common Causes of False Positive Increases in Serum Levels of Cardiac
Troponins

Aleksey   Michailovich   Chaulin

doi:10.2174/1573403X18666220413124038

Abstract

Cardiac troponin molecules (cTnI and cTnT) are the most valuable and in-demand biomarkers for detecting various types of myocardial damage (reversible and irreversible, ischemic, inflammatory, toxic, etc.) in current clinical practice. These biomarkers are widely used for early diagnosis of acute myocardial infarction (AMI) and risk stratification of patients suffering from a number of cardiac (such as myocarditis, heart failure, cardiomyopathy, etc.) and extra-cardiac diseases (such as sepsis, renal failure, pulmonary embolism, neurological pathologies, etc.) that negatively affect the cells of cardiac muscle tissue. However, in daily routine clinical activities, internists and cardiologists often encounter cases of false increases in the concentrations of cardiospecific troponins. A false increase in the concentration of troponins contributes to an incorrect diagnosis and incorrect therapy, which can harm the patient. A false increase in the concentration of troponins contributes to an incorrect diagnosis and incorrect therapy, which can harm the patient, therefore, internists and cardiologists should be well aware of the main reasons and mechanisms for false-positive results cTnI and cTnT. This review article mainly focuses on the causes of falsepositive increases in serum levels of cTnI and cTnT, which provide helpful clues for the accurate diagnosis of AMI and evidence for the differential diagnosis.

Keywords: Cardiovascular diseases, acute myocardial infarction, biomarkers, troponin T, troponin I, false positive.

[1]
Katrukha IA. Human cardiac troponin complex. Structure and functions. Biochemistry (Mosc)  2013; 78(13): 1447-65.
 [http://dx.doi.org/10.1134/S0006297913130063] [PMID: 24490734]

[2]
Ohtsuki I. Troponin: Structure, function and dysfunction. Adv Exp Med Biol  2007; 592: 21-36.
 [http://dx.doi.org/10.1007/978-4-431-38453-3_4] [PMID: 17278353]

[3]
Chaulin AM. Mechanisms for cardiac troponin increase in arterial hypertension. Int J Biom  2021; 11(4): 397-402.
 [http://dx.doi.org/10.21103/Article11(4)_RA2]

[4]
Solaro RJ, Rosevear P, Kobayashi T. The unique functions of cardiac troponin I in the control of cardiac muscle contraction and relaxation. Biochem Biophys Res Commun  2008; 369(1): 82-7.
 [http://dx.doi.org/10.1016/j.bbrc.2007.12.114] [PMID: 18162178]

[5]
Parmacek MS, Solaro RJ. Biology of the troponin complex in cardiac myocytes. Prog Cardiovasc Dis  2004; 47(3): 159-76.
 [http://dx.doi.org/10.1016/j.pcad.2004.07.003] [PMID: 15736582]

[6]
Harada K, Morimoto S. Inherited cardiomyopathies as a troponin disease. Jpn J Physiol  2004; 54(4): 307-18.
 [http://dx.doi.org/10.2170/jjphysiol.54.307] [PMID: 15631686]

[7]
Chaulin AM, Duplyakov DV. Cardiac troponins: Current data on the diagnostic value and analytical characteristics of new determination methods. Cor Vasa  2021; 63(4): 486-93.
 [http://dx.doi.org/10.33678/cor.2021.041]

[8]
Chaulin AM, Grigorieva YV, Pavlova TV, Duplyakov DV. Diagnostic significance of complete blood count in cardiovascular patients. Russ J Cardiol  2020; 25(12): 3923.
 [http://dx.doi.org/10.15829/1560-4071-2020-3923]

[9]
Aldous SJ. Cardiac biomarkers in acute myocardial infarction. Int J Cardiol  2013; 164(3): 282-94.
 [http://dx.doi.org/10.1016/j.ijcard.2012.01.081] [PMID: 22341694]

[10]
Chaulin AM, Duplyakov DV. Biomarkers of acute myocardial infarction: Diagnostic and prognostic value. Part 1 (literature review). J Clin Pract  2020; 11(3): 75-84.
 [http://dx.doi.org/10.17816/clinpract34284]

[11]
Chaulin AM, Duplyakov DV. Biomarkers of acute myocardial infarction: Diagnostic and prognostic value. Part 2 (literature review). J Clin Pract  2020; 11(4): 70-82.
 [http://dx.doi.org/10.17816/clinpract48893]

[12]
Chang AN, Parvatiyar MS, Potter JD. Troponin and cardio-myopathy. Biochem Biophys Res Commun  2008; 369(1): 74-81.
 [http://dx.doi.org/10.1016/j.bbrc.2007.12.081] [PMID: 18157941]

[13]
Reda SM, Chandra M. Dilated cardiomyopathy mutation (R174W) in troponin T attenuates the length-mediated increase in cross-bridge recruitment and myofilament Ca2+ sensitivity. Am J Physiol Heart Circ Physiol  2019; 317(3): H648-57.
 [http://dx.doi.org/10.1152/ajpheart.00171.2019] [PMID: 31373515]

[14]
Fahed AC, Nemer G, Bitar FF, et al. Founder Mutation in N Terminus of Cardiac Troponin I Causes Malignant Hypertrophic Cardiomyopathy. Circ Genom Precis Med  2020; 13(5): 444-52.
 [http://dx.doi.org/10.1161/CIRCGEN.120.002991] [PMID: 32885985]

[15]
Potluri PR, Cordina NM, Kachooei E, Brown LJ. Characterization of the L29Q hypertrophic cardiomyopathy mutation in cardiac troponin c by paramagnetic relaxation enhancement nuclear magnetic resonance. Biochemistry  2019; 58(7): 908-17.
 [http://dx.doi.org/10.1021/acs.biochem.8b01140] [PMID: 30620548]

[16]
Chaulin AM. Updated information about methods of identification and diagnostic opportunities of cardiac troponins. Riv Ital Med Lab  2021; 17(3): 154-64.
 [http://dx.doi.org/10.23736/S1825-859X.21.00116-X]

[17]
Samaha E, Brown J, Brown F, et al. High-sensitivity cardiac troponin T increases after stress echocardiography. Clin Biochem  2019; 63: 18-23.
 [http://dx.doi.org/10.1016/j.clinbiochem.2018.11.013] [PMID: 30502318]

[18]
Lazzarino AI, Hamer M, Gaze D, Collinson P, Steptoe A. The association between cortisol response to mental stress and high-sensitivity cardiac troponin T plasma concentration in healthy adults. J Am Coll Cardiol  2013; 62(18): 1694-701.
 [http://dx.doi.org/10.1016/j.jacc.2013.05.070] [PMID: 23810896]

[19]
Chaulin AM, Duplyakov DV. Environmental factors and cardiovascular diseases. Hyg Sanit  2021; 100(3): 223-8.
 [http://dx.doi.org/10.47470/0016-9900-2021-100-3-223-228]

[20]
Scherr J, Braun S, Schuster T, et al. 72-h kinetics of high-sensitive troponin T and inflammatory markers after marathon. Med Sci Sports Exerc  2011; 43(10): 1819-27.
 [http://dx.doi.org/10.1249/MSS.0b013e31821b12eb] [PMID: 21448080]

[21]
Thygesen K, Alpert JS, Jaffe AS, et al. Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth Universal Definition of Myocardial Infarction (2018). Circulation  2018; 138(20): e618-51.
 [http://dx.doi.org/10.1161/CIR.0000000000000617] [PMID: 30571511]

[22]
Chaulin AM, Karslyan LS, Bazyuk EV, Nurbaltaeva DA, Duplyakov DV. Clinical and diagnostic value of cardiac markers in human biological fluids. Kardiologiia  201959(11): 66-75.
 [http://dx.doi.org/10.18087/cardio.2019.11.n414]

[23]
Chaulin A. Cardiac troponins: Contemporary biological data and new methods of determination. Vasc Health Risk Manag  2021; 17: 299-316.
 [http://dx.doi.org/10.2147/VHRM.S300002] [PMID: 34113117]

[24]
Chaulin AM. Cardiac troponins metabolism: From biochemical mechanisms to clinical practice (literature review). Int J Mol Sci  2021; 22(20): 10928.
 [http://dx.doi.org/10.3390/ijms222010928] [PMID: 34681585]

[25]
Collet JP, Thiele H, Barbato E, et al. ESC Scientific Document Group. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J  2021; 42(14): 1289-367.
 [http://dx.doi.org/10.1093/eurheartj/ehaa575] [PMID: 32860058]

[26]
Chaulin AM, Duplyakov DV. On the potential effect of circadian rhythms of cardiac troponins on the diagnosis of acute myocardial infarction. Signa Vitae  2021; 17(3): 79-84.
 [http://dx.doi.org/10.22514/sv.2021.050]

[27]
Chaulin AM, Abashina OE, Duplyakov DV. High-sensitivity cardiac troponins: Detection and central analytical characteristics. Cardio Therap and Prev  2021; 20(2): 2590.
 [http://dx.doi.org/10.15829/1728-8800-2021-2590]

[28]
Giannitsis E, Katus HA. Cardiac troponin level elevations not related to acute coronary syndromes. Nat Rev Cardiol  2013; 10(11): 623-34.
 [http://dx.doi.org/10.1038/nrcardio.2013.129] [PMID: 23979214]

[29]
Chaulin AM, Abashina OE, Duplyakov DV. Pathophysiological mechanisms of cardiotoxicity in chemotherapeutic agents. Russ Open Med Jol  2020; 9: e0305.
 [http://dx.doi.org/10.15275/rusomj.2020.0305]

[30]
Chaulin AM, Duplyakov DV. Arrhythmogenic effects of doxorubicin. Comp Iss Cardio Dis  2020; 9(3): 69-80.
 [http://dx.doi.org/10.17802/2306-1278-2020-9-3-69-80]

[31]
Lindner G, Pfortmueller CA, Braun CT, Exadaktylos AK. Non-acute myocardial infarction-related causes of elevated high-sensitive troponin T in the emergency room: A cross-sectional analysis. Intern Emerg Med  2014; 9(3): 335-9.
 [http://dx.doi.org/10.1007/s11739-013-1030-y] [PMID: 24326466]

[32]
Chaulin AM. Main analytical characteristics of laboratory methods for the determination of cardiac troponins: A review from the historical and modern points of view. Orv Hetil  2022; 163(1): 12-20.
 [http://dx.doi.org/10.1556/650.2022.32296] [PMID: 34974429]

[33]
Chaulin AM, Grigorieva JV, Suvorova GN, Duplyakov DV. Experimental modeling of hypothyroidism: Principles, methods, several advanced research directions in cardiology. Russ Open Med J  2021; 10(3): e0311.
 [http://dx.doi.org/10.15275/rusomj.2021.0311]

[34]
Chaulin AM. Phosphorylation and fragmentation of the cardiac troponin T: Mechanisms, role in pathophysiology and laboratory diagnosis. Int J Biom  2021; 11(3): 250-9.
 [http://dx.doi.org/10.21103/Article11(3)_RA2]

[35]
Chaulin AM, Duplyakov DV. Comorbidity in chronic obstructive pulmonary disease and cardiovascular disease. Cardio Ther and Preven  2021; 20(3): 2539.
 [http://dx.doi.org/10.15829/1728-8800-2021-2539]

[36]
Nosanchuk JS, Combs B, Abbott G. False increases of troponin I attributable to incomplete separation of serum. Clin Chem  1999; 45(5): 714.
 [http://dx.doi.org/10.1093/clinchem/45.5.714] [PMID: 10222366]

[37]
Roberts WL, Calcote CB, De BK, Holmstrom V, Narlock C, Apple FS. Prevention of analytical false-positive increases of cardiac troponin I on the Stratus II analyzer. Clin Chem  1997; 43(5): 860-1.
 [http://dx.doi.org/10.1093/clinchem/43.5.860] [PMID: 9166253]

[38]
Lum G, Solarz DE, Farney L. False positive cardiac troponin results in patients without acute myocardial infarction. Lab Med  2006; 37(9): 546-50.
 [http://dx.doi.org/10.1309/T94UUXTJ3TX5Y9W2]

[39]
Lippi G, Aloe R, Meschi T, Borghi L, Cervellin G. Interference from heterophilic antibodies in troponin testing. Case report and systematic review of the literature. Clin Chim Acta  2013; 426: 79-84.
 [http://dx.doi.org/10.1016/j.cca.2013.09.004] [PMID: 24041812]

[40]
Butch AW, Goodnow TT, Brown WS, McClellan A, Kessler G, Scott MG. Stratus automated creatine kinase-MB assay evaluated: Identification and elimination of falsely increased results associated with a high-molecular-mass form of alkaline phosphatase. Clin Chem  1989; 35(10): 2048-53.
 [http://dx.doi.org/10.1093/clinchem/35.10.2048] [PMID: 2676240]

[41]
Dasgupta A, Chow L, Wells A, Datta P. Effect of elevated concentration of alkaline phosphatase on cardiac troponin I assays. J Clin Lab Anal  2001; 15(4): 175-7.
 [http://dx.doi.org/10.1002/jcla.1023] [PMID: 11436198]

[42]
Katwa G, Komatireddy G, Walker SE. False positive elevation of cardiac troponin I in seropositive rheumatoid arthritis. J Rheumatol  2001; 28(12): 2750-1.
 [PMID: 11764229]

[43]
Li SF, Zapata J, Tillem E. The prevalence of false-positive cardiac troponin I in ED patients with rhabdomyolysis. Am J Emerg Med  2005; 23(7): 860-3.
 [http://dx.doi.org/10.1016/j.ajem.2005.05.008] [PMID: 16291441]

[44]
Punukollu G, Gowda RM, Khan IA, et al. Elevated serum cardiac troponin I in rhabdomyolysis. Int J Cardiol  2004; 96(1): 35-40.
 [http://dx.doi.org/10.1016/j.ijcard.2003.04.053] [PMID: 15203259]

[45]
Egholm G, Pareek M. Drug-induced rhabdomyolysis with elevated cardiac troponin T. Case Rep Med  2015; 2015: 270204.
 [http://dx.doi.org/10.1155/2015/270204] [PMID: 26557852]

[46]
Chaulin AM, Duplyakova PD, Duplyakov DV. Circadian rhythms of cardiac troponins: Mechanisms and clinical significance. Russ J Cardio  2020; 25(3S): 4061.
 [http://dx.doi.org/10.15829/1560-4071-2020-4061]

[47]
Chaulin AM, Duplyakova PD, Bikbaeva GR, Tukhbatova AA, Grigorieva EV, Duplyakov DV. Concentration of high-sensitivity cardiac troponin I in the oral fluid in patients with acute myocardial infarction: A pilot study. Russ J Cardio  2020; 25(12): 3814.
 [http://dx.doi.org/10.15829/1560-4071-2020-3814]

[48]
Hyytiä H, Heikkilä T, Hedberg P, Puolakanaho T, Pettersson K. Skeletal troponin I cross-reactivity in different cardiac troponin I assay versions. Clin Biochem  2015; 48(4-5): 313-7.
 [http://dx.doi.org/10.1016/j.clinbiochem.2014.12.028] [PMID: 25583092]

[49]
Reichstein E. The importance of preanalytical factors in immunodiagnostic testing. EJIFCC  2003; 14(3): 124-7.
 [PMID: 30275811]

[50]
Beyne P, Vigier JP, Bourgoin P, Vidaud M. Comparison of single and repeat centrifugation of blood specimens collected in BD evacuated blood collection tubes containing a clot acti-vator for cardiac troponin I assay on the ACCESS analyzer. Clin Chem  2000; 46(11): 1869-70.
 [http://dx.doi.org/10.1093/clinchem/46.11.1869] [PMID: 11067839]

[51]
Kaplan IV, Levinson SS. When is a heterophile antibody not a heterophile antibody? When it is an antibody against a specific immunogen. Clin Chem  1999; 45(5): 616-8.
 [http://dx.doi.org/10.1093/clinchem/45.5.616] [PMID: 10222346]

[52]
Kricka LJ. Human anti-animal antibody interferences in immunological assays. Clin Chem  1999; 45(7): 942-56.
 [http://dx.doi.org/10.1093/clinchem/45.7.942] [PMID: 10388468]

[53]
Lahat Y, Shiloah E, Rapoport M. Recurrent hospitalizations due to false positive troponin in a patient presenting with chest pain. Harefuah  2009; 148(6): 359-61.
 [PMID: 19902597]

[54]
Manjunath L, Yeluru A, Rodriguez F. 27-Year-old man with a positive troponin: A case report. Cardiol Ther  2018; 7(2): 197-204.
 [http://dx.doi.org/10.1007/s40119-018-0120-3] [PMID: 30367446]

[55]
Zaidi A, Cowell R. False positive cardiac troponin elevation due to heterophile antibodies: More common than we recognise? BMJ Case Rep  2010; 2010(jul15 3): bcr1120092477.
 [http://dx.doi.org/10.1136/bcr.11.2009.2477] [PMID: 22752944]

[56]
Nguyen J, Thachil R, Vyas N, Marino T. Falsely elevated troponin: Rare occurrence or future problem. J Community Hosp Intern Med Perspect  2016; 6(6): 32952.
 [http://dx.doi.org/10.3402/jchimp.v6.32952] [PMID: 27987279]

[57]
Marinheiro R, Amador P, Parreira L, Rato Q, Caria R. False positive troponin i rendering two admissions for “Recurrent acute myopericarditis”. Open Cardiovasc Med J  2018; 12(1): 55-8.
 [http://dx.doi.org/10.2174/1874192401812010055] [PMID: 30069255]

[58]
Herman DS, Ranjitkar P, Yamaguchi D, Grenache DG, Greene DN. Endogenous alkaline phosphatase interference in cardiac troponin I and other sensitive chemiluminescence immunoassays that use alkaline phosphatase activity for signal amplification. Clin Biochem  2016; 49(15): 1118-21.
 [http://dx.doi.org/10.1016/j.clinbiochem.2016.06.006] [PMID: 27317886]

[59]
Ugolini A, Nuti M. Rheumatoid factor: A novel determiner in cancer history. Cancers (Basel)  2021; 13(4): 591.
 [http://dx.doi.org/10.3390/cancers13040591] [PMID: 33546243]

[60]
Bas S, Genevay S, Mensi N. False positive elevation of cardiac troponin I in seropositive rheumatoid arthritis. J Rheumatol  2002; 29(12): 2665.
 [PMID: 12465175]

[61]
Dasgupta A, Banerjee SK, Datta P. False-positive troponin I in the MEIA due to the presence of rheumatoid factors in serum. Elimination of this interference by using a polyclonal antisera against rheumatoid factors. Am J Clin Pathol  1999; 112(6): 753-6.
 [http://dx.doi.org/10.1093/ajcp/112.6.753] [PMID: 10587696]

[62]
Kenny PR, Finger DR. Falsely elevated cardiac troponin-I in patients with seropositive rheumatoid arthritis. J Rheumatol  2005; 32(7): 1258-61.
 [PMID: 15996061]

[63]
Al-Awadhi AM, Olusi S, Hasan EA, Abdullah A. Serum concentrations of cardiac troponin-I in patients with rheumatoid arthritis, systemic lupus erythematosus, primary Sjogren’s syndrome and Graves’ disease. Singapore Med J  2007; 48(9): 847-9.
 [PMID: 17728967]

[64]
Marks V. False-positive immunoassay results: A multicenter survey of erroneous immunoassay results from assays of 74 analytes in 10 donors from 66 laboratories in seven countries. Clin Chem  2002; 48(11): 2008-16.
 [http://dx.doi.org/10.1093/clinchem/48.11.2008] [PMID: 12406987]

[65]
Lavoinne A, Hue G. Serum cardiac troponins I and T in early posttraumatic rhabdomyolysis. Clin Chem  1998; 44(3): 667-8.
 [http://dx.doi.org/10.1093/clinchem/44.3.667] [PMID: 9510880]

[66]
Aggarwal R, Lebiedz-Odrobina D, Sinha A, Manadan A, Case JP. Serum cardiac troponin T, but not troponin I, is elevated in idiopathic inflammatory myopathies. J Rheumatol  2009; 36(12): 2711-4.
 [http://dx.doi.org/10.3899/jrheum.090562] [PMID: 19833747]

[67]
Schmid J, Liesinger L, Birner-Gruenberger R, et al. Elevated cardiac troponin T in patients with skeletal myopathies. J Am Coll Cardiol  2018; 71(14): 1540-9.
 [http://dx.doi.org/10.1016/j.jacc.2018.01.070] [PMID: 29622161]

[68]
Messner B, Baum H, Fischer P, Quasthoff S, Neumeier D. Expression of messenger RNA of the cardiac isoforms of troponin T and I in myopathic skeletal muscle. Am J Clin Pathol  2000; 114(4): 544-9.
 [http://dx.doi.org/10.1309/8KCL-UQRF-6EEL-36XK] [PMID: 11026100]

[69]
Ricchiuti V, Apple FS. RNA expression of cardiac troponin T isoforms in diseased human skeletal muscle. Clin Chem  1999; 45(12): 2129-35.
 [http://dx.doi.org/10.1093/clinchem/45.12.2129] [PMID: 10585344]

[70]
Wens SC, Schaaf GJ, Michels M, et al. Elevated plasma cardiac troponin T levels caused by skeletal muscle damage in pompe disease. Circ Cardiovasc Genet  2016; 9(1): 6-13.
 [http://dx.doi.org/10.1161/CIRCGENETICS.115.001322] [PMID: 26787432]

[71]
Schmid J, Birner-Gruenberger R, Liesinger L, et al. Elevated cardiac troponin T but not troponin I in patients with skeletal muscle disease. Eur Heart J  2017; 38(1)
 [http://dx.doi.org/10.1093/eurheartj/ehx502.P2612]

[72]
Chaulin AM. Cardiac troponins: Current information on the main analytical characteristics of determination methods and new diagnostic possibilities. Medwave  2021; 21(11): e8498.
 [http://dx.doi.org/10.5867/medwave.2021.11.002132] [PMID: 34890387]

[73]
Chaulin A. Clinical and diagnostic value of highly sensitive cardiac troponins in arterial hypertension. Vasc Health Risk Manag  2021; 17: 431-43.
 [http://dx.doi.org/10.2147/VHRM.S315376] [PMID: 34366667]

Rights & Permissions Print Cite

Article Metrics

10

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/1573403X18666220413124038	Print ISSN 1573-403X
Publisher Name Bentham Science Publisher	Online ISSN 1875-6557

Current Cardiology Reviews

Some Common Causes of False Positive Increases in Serum Levels of Cardiac Troponins

Abstract Play Pause

Related Journals

Related Books

Abstract